Corporate Banner
Satellite Banner
Scientific Community
Become a Member | Sign in
Home>News>This Article

JAX and Frasergen Announce Cancer Genomics Facility in Hubei Province, China

Published: Tuesday, June 10, 2014
Last Updated: Tuesday, June 10, 2014
Bookmark and Share
Researchers investigate cancers and their response to novel drugs and immunotherapies using the Laboratory’s innovative cancer tools.

The Jackson Laboratory (JAX) in conjunction with the Chinese company Wuhan Frasergen Bioinformatics Co., Ltd. has announced the creation of a facility in Wuhan, China, that will enable researchers there to investigate cancers and their response to novel drugs and immunotherapies using the Laboratory’s innovative cancer tools according to a memorandum of understanding (MOU) announced in Wuhan on June 7.

Jackson Laboratory Executive Vice President Charles E. Hewett and Frasergen Bioinformatics CEO Chen Dongsheng have announced plans to establish a facility in the Biolake, Wuhan, Hubei Province. Government officials from the province of Hubei and city of Wuhan attended the signing ceremony at the Queen Palace Hotel in Wuhan.

"This new arrangement will put JAX and Frasergen in the center of the Chinese biomedical research and services community," said Hewett. "We are excited to gain a foothold in this rapidly growing arena and look forward to working with our Chinese colleagues to help develop better cancer treatments and cures for people around the world. We value Frasergen’s strong and rapidly expanding bioinformatics capabilities and, even more, their integrity and commitment to mitigating the scourge of cancer."

Dongsheng Chen, CEO of Frasergen, praised the agreement. "JAX makes a terrific partner for Frasergen," said Chen. "We carefully vetted them over an 18-month period and welcome the opportunity to bring their experience and tools to Wuhan." Both Chen and Hewett expressed hope that this initial arrangement could grow into even more significant opportunities for their organizations to collaborate as their relationship matures.

Dr. Deng Zixin, President of Wuhan Institute of Biotechnology and a fellow of the Chinese Academy of Sciences praised the new development at Wuhan BioLake: "The joint effort between Jackson Laboratory and Frasergen will enhance biomedical research capacity in Wuhan and throughout China. It will promote translational medicine and enable a coherent transfer of basic research to clinical medicine," he commented.

The Jackson Laboratory-Frasergen collaboration in China will foster development in drug discovery and pharmaceuticals focused on personalized medicine. "Hopefully, the facility in the Wuhan BioLake will create new services," commented JAX President and CEO Edison Liu, "with customers from both basic research and industrial institutions. On the one hand, it supports research and provides services in personalized medicine in cancer and hereditary disease conditions, on the other hand, it supports the research needs for pharmaceutical entities using the technology and resources from The Jackson Laboratory."

Wuhan, a city of 10 million in Hubei Province in east-central China, lies at the hub of Chinese transportation systems and hosts a major center for the Chinese Academy of Sciences. Together, JAX and Frasergen will study tumors donated by Chinese patients, characterize them, and create a repository that will be available to support both academic and corporate scientists.

JAX’s severely immune-compromised mouse, known as the NSG, will be used as a host for growing and expanding the tumors as researchers strive to understand their fundamental biology as well as the response of tumors with defined characteristics to specific therapies.

Reflecting on the potential impact on JAX’s work in the United States, Hewett noted that he expects the Chinese endeavor to be complementary to the Lab’s sites in Maine, Connecticut and California. All three JAX locations are involved in various aspects of similar research and will benefit from shared data, intellectual collaboration, and opportunities to sell mice and services to the new Chinese entity.

Noting that the new agreement, besides advancing China’s own cancer research efforts, will help JAX in the US with its own, Liu said, "The scale of this project will greatly accelerate our accumulation of detailed genomic profiles of patient cancers and, through their study, enable more accurate therapeutic prescriptions for future patients."

Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,800+ scientific posters on ePosters
  • More than 4,000+ scientific videos on LabTube
  • 35 community eNewsletters

Sign In

Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

JAX Receives Funding for Genomics
David and Barbara Roux provide historic $10 million gift to advance genomic medicine research at JAX.
Wednesday, October 22, 2014
JAX and BIDMC Announce Multi-faceted Affiliation
Collaboration will encompass a broad range of activities to advance cancer research and patient care.
Tuesday, September 23, 2014
Scientific News
New Tech Vastly Improves CRISPR/Cas9 Accuracy
A new CRISPR/Cas9 technology developed by scientists at UMass Medical School is precise enough to surgically edit DNA at nearly any genomic location, while avoiding potentially harmful off-target changes typically seen in standard CRISPR gene editing techniques.
New Class of RNA Tumor Suppressors Identified
Two short, “housekeeping” RNA molecules block cancer growth by binding to an important cancer-associated protein called KRAS. More than a quarter of all human cancers are missing these RNAs.
Biologists Induce Flatworms to Grow Heads and Brains of Other Species
Findings shed light on role of a new kind of epigenetic signaling in evolution, could yield clues for understanding birth defects and regeneration.
Turning up the Tap on Microbes Leads to Better Protein Patenting
Mining millions of proteins could become faster and easier with a new technique that may also transform the enzyme-catalyst industry, according to University of California, Davis, researchers.
Mathematical Model Forecasts the Path of Breast Cancer
Chances of survival depend on which organs breast cancer tumors colonize first.
Exploring the Causes of Cancer
Queen's research to understand the regulation of a cell surface protein involved in cancer.
Ancient Viral Molecules Essential for Human Development
Genetic material from ancient viral infections is critical to human development, according to researchers at the Stanford University School of Medicine.
Tardigrade's Are DNA Master Thieves
Tardigrades, nearly microscopic animals that can survive the harshest of environments, including outer space, hold the record for the animal that has the most foreign DNA.
The Secret Behind the Power of Bacterial Sex
Migration between different communities of bacteria is the key to the type of gene transfer that can lead to the spread of traits such as antibiotic resistance, according to researchers at Oxford University.
Farming’s in Their DNA
Ancient genomes reveal natural selection in action.
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,800+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,000+ scientific videos